FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2399697645> ?p ?o ?g. }

• W2399697645 abstract "Abstract Background EBV-associated post-transplant lymphoproliferative disorder (EBV-PTLD) is uncommon but one of serious complications after allogeneic stem cell transplantation (SCT). However, there has been little literature published on clinicopathological feature of it. Method We retrospectively investigated 825 cases of allogeneic SCT (unrelated bone marrow (uBM) 159, related peripheral blood (rPB) 94, cord blood (CB) 572) at Toranomon Hospital between January 2006 to November 2012. EBV-PTLD was defined as histologically confirmed Epstein-Barr virus (EBV) positive lymphoproliferative disorder developed after allogeneic SCT. Results We identified 12 cases of EBV-PTLD in our cohort. Cumulative incidence of EBV-PTLD at 2 years was 1.5%. Median time from allogeneic SCT to the diagnosis of EBV-PTLD was 6.4 (2.5-26) months. Eight patients were male and median age at the diagnosis of EBV-PTLD was 58.5 years (28-66). Underlying diseases were acute myeloid leukemia (n=5), myelodysplastic syndrome (1), acute lymphoblastic leukemia (2), adult T cell leukemia-lymphoma (1), aplastic anemia (2) and chronic myeloid leukemia in blastic phase (1). Conditioning regimens were fludarabine-based (n=10) and TBI/CY (n=2). None had an antithymocyte globulin-containing regimen. Donor sources were uBM (n=1) and CB (11). EBV serology before allogeneic SCT was tested in 11 and all were positive. Patients who received CB showed higher incidence of EBV-PTLD compared to those in non-CB cohort (2.2% vs 0.6%, p < 0.01), although patients characteristics was different between them. One patient developed PTLD after third allogeneic SCT. All but one patients had a history of acute graft-versus-host disease (aGVHD) of grade I (n=2), grade II (6) and grade III (3), respectively. Chronic GVHD was observed in 6 patients. Eight patients were on immunosuppressive therapy (IST) with calcineurin inhibitors and/or steroids when EBV-PTLD was suspected for the first time. Although lymphadenopathy was detected by CT scan in 7 patients, surface lymph nodes were swollen in only 3 patients. Initial manifestations were fever in 8, and diarrhea in 5 patients. EBV-PTLD was diagnosed from lymph nodes (n=3), skin (3), bone marrow (2), stomach/duodenum (1), colon (2), and lung (1), respectively. Histological feature was monomorphic (n=4), polymorphic (2), early lesion (4), and unknown (2), respectively. LMP1 and EBNA2 was positive in 40% (4/10) and 30% (3/10), suggesting latency status of I in 50% (6/12), II in 8.3% (1/12), III in 25% (3/12), and unknown in 16.7% (2/12). EBV DNA of 100 copies/microL or above was detected in peripheral blood in all of the EBV-PTLD cases. The treatment for EBV-PTLD were rituximab alone (n=3), rituximab plus reduction of IST (6), rituximab plus cytotoxic chemotherapy (1), and observation alone(2). Although 8 patients achieved response, 2 patients suffered a relapse of EBV-PTLD. With a median follow up of 27.5 (4.1-47.7) months, 2-year overall survival was 46.9% after diagnosis of EBV-PTLD. Eight patients died and 4 are alive without relapse of EBV-PTLD. Causes of death were EBV-PTLD (n=2), relapse of underlying disease(3), infectious disease(2), and aGVHD(1). Conclusion Twelve cases of EBV-PTLD were identified in 825 transplants. Cumulative incidence of EBV-PTLD at 2 years was 1.5%. The incidence of EBV-PTLD after CB transplant was higher than that after non CB transplant, although we have to take into consideration that patients feature was different between them. Response to rituximab and/or reduction of IST was observed in 8 patients with a 2-year overall survival rate of 46.9%. Patients with prior aGVHD and with longer duration of immunosuppressive therapy may have an increased risk of developing EBV-PTLD. Since the initial manifestations were often equivocal, and survival rate after diagnosis is not high, having EBV-PTLD in mind as one of the possibilities is critical for prompt diagnosis. Disclosures: No relevant conflicts of interest to declare." @default.
• W2399697645 created "2016-06-24" @default.
• W2399697645 creator A5007951151 @default.
• W2399697645 creator A5009982513 @default.
• W2399697645 creator A5010644978 @default.
• W2399697645 creator A5020301016 @default.
• W2399697645 creator A5027118202 @default.
• W2399697645 creator A5028679667 @default.
• W2399697645 creator A5032028535 @default.
• W2399697645 creator A5057554279 @default.
• W2399697645 creator A5057971304 @default.
• W2399697645 creator A5059414275 @default.
• W2399697645 creator A5075804426 @default.
• W2399697645 creator A5085077147 @default.
• W2399697645 creator A5086795216 @default.
• W2399697645 date "2013-11-15" @default.
• W2399697645 modified "2023-09-28" @default.
• W2399697645 title "Clinicopathological Study Of 12 Cases Of EBV-Associated Post-Transplant Lymphoproliferative Disorder (PTLD) After Allogeneic SCT: A Single Institution Analysis Of 825 Transplants Including 572 Cord Blood Transplants In Toranomon Hospital" @default.
• W2399697645 doi "https://doi.org/10.1182/blood.v122.21.3323.3323" @default.
• W2399697645 hasPublicationYear "2013" @default.
• W2399697645 type Work @default.
• W2399697645 sameAs 2399697645 @default.
• W2399697645 citedByCount "0" @default.
• W2399697645 crossrefType "journal-article" @default.
• W2399697645 hasAuthorship W2399697645A5007951151 @default.
• W2399697645 hasAuthorship W2399697645A5009982513 @default.
• W2399697645 hasAuthorship W2399697645A5010644978 @default.
• W2399697645 hasAuthorship W2399697645A5020301016 @default.
• W2399697645 hasAuthorship W2399697645A5027118202 @default.
• W2399697645 hasAuthorship W2399697645A5028679667 @default.
• W2399697645 hasAuthorship W2399697645A5032028535 @default.
• W2399697645 hasAuthorship W2399697645A5057554279 @default.
• W2399697645 hasAuthorship W2399697645A5057971304 @default.
• W2399697645 hasAuthorship W2399697645A5059414275 @default.
• W2399697645 hasAuthorship W2399697645A5075804426 @default.
• W2399697645 hasAuthorship W2399697645A5085077147 @default.
• W2399697645 hasAuthorship W2399697645A5086795216 @default.
• W2399697645 hasConcept C126322002 @default.
• W2399697645 hasConcept C203014093 @default.
• W2399697645 hasConcept C2776694085 @default.
• W2399697645 hasConcept C2776755627 @default.
• W2399697645 hasConcept C2776995267 @default.
• W2399697645 hasConcept C2779263901 @default.
• W2399697645 hasConcept C2779338263 @default.
• W2399697645 hasConcept C2780653079 @default.
• W2399697645 hasConcept C2780914630 @default.
• W2399697645 hasConcept C2781146716 @default.
• W2399697645 hasConcept C2911091166 @default.
• W2399697645 hasConcept C71924100 @default.
• W2399697645 hasConcept C88879693 @default.
• W2399697645 hasConcept C90924648 @default.
• W2399697645 hasConceptScore W2399697645C126322002 @default.
• W2399697645 hasConceptScore W2399697645C203014093 @default.
• W2399697645 hasConceptScore W2399697645C2776694085 @default.
• W2399697645 hasConceptScore W2399697645C2776755627 @default.
• W2399697645 hasConceptScore W2399697645C2776995267 @default.
• W2399697645 hasConceptScore W2399697645C2779263901 @default.
• W2399697645 hasConceptScore W2399697645C2779338263 @default.
• W2399697645 hasConceptScore W2399697645C2780653079 @default.
• W2399697645 hasConceptScore W2399697645C2780914630 @default.
• W2399697645 hasConceptScore W2399697645C2781146716 @default.
• W2399697645 hasConceptScore W2399697645C2911091166 @default.
• W2399697645 hasConceptScore W2399697645C71924100 @default.
• W2399697645 hasConceptScore W2399697645C88879693 @default.
• W2399697645 hasConceptScore W2399697645C90924648 @default.
• W2399697645 hasLocation W23996976451 @default.
• W2399697645 hasOpenAccess W2399697645 @default.
• W2399697645 hasPrimaryLocation W23996976451 @default.
• W2399697645 hasRelatedWork W2056474706 @default.
• W2399697645 hasRelatedWork W2065676202 @default.
• W2399697645 hasRelatedWork W2090235724 @default.
• W2399697645 hasRelatedWork W2463800538 @default.
• W2399697645 hasRelatedWork W2501256008 @default.
• W2399697645 hasRelatedWork W2553676655 @default.
• W2399697645 hasRelatedWork W2555171526 @default.
• W2399697645 hasRelatedWork W2555283572 @default.
• W2399697645 hasRelatedWork W2559954278 @default.
• W2399697645 hasRelatedWork W2560104443 @default.
• W2399697645 hasRelatedWork W2581017607 @default.
• W2399697645 hasRelatedWork W2587405715 @default.
• W2399697645 hasRelatedWork W2615041245 @default.
• W2399697645 hasRelatedWork W2792111164 @default.
• W2399697645 hasRelatedWork W2900911231 @default.
• W2399697645 hasRelatedWork W2961765674 @default.
• W2399697645 hasRelatedWork W2968887422 @default.
• W2399697645 hasRelatedWork W3012708229 @default.
• W2399697645 hasRelatedWork W3030990635 @default.
• W2399697645 hasRelatedWork W3132540377 @default.
• W2399697645 isParatext "false" @default.
• W2399697645 isRetracted "false" @default.
• W2399697645 magId "2399697645" @default.
• W2399697645 workType "article" @default.